China Institute of Atomic Energy Holds Advanced Scientific and Technological Achievements Transformation Conference: Releases Small Reactor 9-Type Product Matrix, Signs Agreements on Curie-Level Terbium-161 Preparation and SMR Overall Scheme Design

On September 29, the China Institute of Atomic Energy (abbreviated as “CIAE”) held in Beijing an Advanced Scientific and Technological Achievements Transformation Conference themed “Innovation · Nuclear Fusion of New Quality.” The conference showcased CIAE's practical breakthroughs in deepening scientific and technological system reform, advancing the pilot program for empowering scientific and technological achievements from job-related inventions, and integrated institute-enterprise operations, and officially released multiple major scientific research achievements covering advanced reactors, nuclear medical equipment, and isotope preparation, vigorously promoting the acceleration of nuclear technology from the “laboratory” to the “production line.”

In the report on reform experience and benchmark incubation platforms, the conference systematically summarized three landmark reform achievements:

SASAC Pilot Reform for Empowering Scientific and Technological Achievements from Job-Related Inventions: CIAE established a high-tech entity through capital contribution in the form of the “Technology for Producing Ge-68 (Germanium-68) Radioactive Medical Isotopes Based on a 75MeV High-Intensity Proton Cyclotron,” exploring a compliant and efficient new model for scientific research institutes to make capital contributions with scientific and technological achievements and equity incentives;

Jointly Building a High-Level R&D Entity “Lingxiao Laboratory”: This laboratory is jointly built by CIAE and the People's Government of Huludao City, Liaoning Province. Relying on its six major R&D centers, it focuses on malignant tumors, cardiovascular and cerebrovascular diseases, and neurodegenerative diseases, comprehensively tackling the source research and clinical translation of novel radiotheranostic integrated radiopharmaceuticals;

“Institute-Enterprise Integration” Restructuring of Industrial Entities: Since Guoyuan Company, a wholly-owned subsidiary of CIAE, implemented integrated management with the Institute of Nuclear Safety and Environmental Engineering Technology in 2025, it has accelerated the removal of technology transformation bottlenecks, successively launching high-barrier hard-tech products such as smart radiation monitoring watches and nuclear radiation inspection robots, achieving a rapid transformation from traditional services to intelligent special nuclear equipment manufacturing.

In the core technology achievement roadshow session, CIAE selected 4 industrialization projects from its major scientific research accumulations since the “14th Five-Year Plan” that target major national strategies and the main industrial battlefield:

Small Reactor Industrialization Promotion Project: Officially launched a full-spectrum small modular reactor (SMR) product matrix including 9 reactor type products, comprehensively covering multi-dimensional complex scenarios such as island power supply, distributed heating in remote areas, industrial high-quality steam, and cogeneration;

“Xuan Guang” Series Cyclotron Products: Building a full-chain equipment foundation spanning high-purity medical isotope mass production, high-end nuclear medicine imaging diagnosis, to precision heavy ion/proton radiotherapy for tumors;

Laser-Induced Breakdown Spectroscopy Composition Detector (LIBS): Targeting advanced nuclear materials and industrial in-situ detection, achieving online ultrafast non-destructive monitoring of production material composition and material erosion status;

Irradiation Breeding Electron Linear Accelerator Device: Implementing customized high-energy electron irradiation mutagenesis for multiple categories of crop seeds and seedlings, significantly improving the mutagenesis precision and breeding efficiency of modern agricultural biological breeding.

The conference also held a centralized signing ceremony for 4 key industrialization projects. According to the signed strategic and commercial agreements, CIAE will deeply collaborate with industrial partners and financial capital, focusing on comprehensive in-depth cooperation in Curie-scale novel medical isotope Terbium-161 (Tb-161) preparation technology, pre-research and overall scheme design of small modular reactors (SMR), co-building overseas nuclear technology application market channels, and implementation of the “technology-industry-finance” industry-finance synergy mechanism, providing solid technical support for CNNC to expand its frontier civilian nuclear technology territory and global business layout.